Id |
Subject |
Object |
Predicate |
Lexical cue |
T1 |
0-100 |
Sentence |
denotes |
The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients. |
T1 |
0-100 |
Sentence |
denotes |
The acetylcholinesterase inhibitor, Donepezil, regulates a Th2 bias in Alzheimer's disease patients. |
T2 |
101-204 |
Sentence |
denotes |
The increased pro-inflammatory cytokine production was previously observed in Alzheimer's disease (AD). |
T2 |
101-204 |
Sentence |
denotes |
The increased pro-inflammatory cytokine production was previously observed in Alzheimer's disease (AD). |
T3 |
205-357 |
Sentence |
denotes |
We sought to explore whether acetylcholinesterase inhibitor (AChEI) therapy ameliorates clinical symptoms in AD through down-regulation of inflammation. |
T3 |
205-357 |
Sentence |
denotes |
We sought to explore whether acetylcholinesterase inhibitor (AChEI) therapy ameliorates clinical symptoms in AD through down-regulation of inflammation. |
T4 |
358-604 |
Sentence |
denotes |
Expression and release of monocyte chemotactic protein-1 (MCP-1), a positive regulator of Th2 differentiation, and interleukin (IL)-4, an anti-inflammatory cytokine from peripheral blood mononuclear cells (PBMC) in AD patients, were investigated. |
T4 |
358-604 |
Sentence |
denotes |
Expression and release of monocyte chemotactic protein-1 (MCP-1), a positive regulator of Th2 differentiation, and interleukin (IL)-4, an anti-inflammatory cytokine from peripheral blood mononuclear cells (PBMC) in AD patients, were investigated. |
T5 |
605-746 |
Sentence |
denotes |
PBMC were purified from AD patients at time of enrollment (T0) and after 1 month of treatment with AChEI (T1) and from healthy controls (HC). |
T5 |
605-746 |
Sentence |
denotes |
PBMC were purified from AD patients at time of enrollment (T0) and after 1 month of treatment with AChEI (T1) and from healthy controls (HC). |
T6 |
747-854 |
Sentence |
denotes |
Supernatants were analyzed for cytokine levels by ELISA methods. mRNA expression were determined by RT-PCR. |
T6 |
747-854 |
Sentence |
denotes |
Supernatants were analyzed for cytokine levels by ELISA methods. mRNA expression were determined by RT-PCR. |
T7 |
855-1050 |
Sentence |
denotes |
Expression and production of MCP-1 and IL-4 were significantly increased in AD subjects under therapy with the AChEI Donepezil, compared to the same AD patients at time of enrollment (P < 0.001). |
T7 |
855-1050 |
Sentence |
denotes |
Expression and production of MCP-1 and IL-4 were significantly increased in AD subjects under therapy with the AChEI Donepezil, compared to the same AD patients at time of enrollment (P < 0.001). |
T8 |
1051-1377 |
Sentence |
denotes |
Our data suggest another possible explanation for the ability of Donepezil [diethyl(3,5-di-ter-butyl-4-hydroxybenzyl)phosphonate] to delay the progression of AD; in fact, Donepezil may modulate MCP-1 and IL-4 production, which may reflect a general shift towards type Th0/Th2 cytokines which could be protective in AD disease. |
T8 |
1051-1377 |
Sentence |
denotes |
Our data suggest another possible explanation for the ability of Donepezil [diethyl(3,5-di-ter-butyl-4-hydroxybenzyl)phosphonate] to delay the progression of AD; in fact, Donepezil may modulate MCP-1 and IL-4 production, which may reflect a general shift towards type Th0/Th2 cytokines which could be protective in AD disease. |
T9 |
1378-1593 |
Sentence |
denotes |
The different amounts of MCP-1 and IL-4 observed might reflect the different states of activation and/or responsiveness of PBMC, that in AD patients could be kept in an activated state by pro-inflammatory cytokines. |
T9 |
1378-1593 |
Sentence |
denotes |
The different amounts of MCP-1 and IL-4 observed might reflect the different states of activation and/or responsiveness of PBMC, that in AD patients could be kept in an activated state by pro-inflammatory cytokines. |